Cole, Evan S.Allen, LindsayAustin, AnnaBarnes, AndrewChang, Chung-Chou H.Clark, SarahCrane, DushkaCunningham, PeterFry, Carrie E.Gordon, Adam J.Hammerslag, LindseyIdala, DavidKennedy, SusanKim, Joo YeonKrishnan, SunitaLanier, PaulMahakalanda, ShyamaMauk, RachelMcDuffie, Mary JoanMohamoud, ShamisTalbert, JeffTang, LuZivin, KaraDonohue, Julie M.2025-01-222025-01-222022-12-01Cole, Evan S., Lindsay Allen, Anna Austin, Andrew Barnes, Chung-Chou H. Chang, Sarah Clark, Dushka Crane, et al. "Outpatient Follow-up and Use of Medications for Opioid Use Disorder after Residential Treatment among Medicaid Enrollees in 10 States". Drug and Alcohol Dependence 241 (1 December 2022): 109670. https://doi.org/10.1016/j.drugalcdep.2022.109670.https://doi.org/10.1016/j.drugalcdep.2022.109670http://hdl.handle.net/11603/37350BackgroundFollow-up after residential treatment is considered best practice in supporting patients with opioid use disorder (OUD) in their recovery. Yet, little is known about rates of follow-up after discharge. The objective of this analysis was to measure rates of follow-up and use of medications for OUD (MOUD) after residential treatment among Medicaid enrollees in 10 states, and to understand the enrollee and episode characteristics that are associated with both outcomes.MethodsUsing a distributed research network to analyze Medicaid claims data, we estimated the likelihood of 4 outcomes occurring within 7 and 30 days post-discharge from residential treatment for OUD using multinomial logit regression: no follow-up or MOUD, follow-up visit only, MOUD only, or both follow-up and MOUD. We used meta-analysis techniques to pool state-specific estimates into global estimates.ResultsWe identified 90,639 episodes of residential treatment for OUD for 69,017 enrollees from 2018 to 2019. We found that 62.5% and 46.9% of episodes did not receive any follow-up or MOUD at 7 days and 30 days, respectively. In adjusted analyses, co-occurring mental health conditions, longer lengths of stay, prior receipt of MOUD or behavioral health counseling, and a recent ED visit for OUD were associated with a greater likelihood of receiving follow-up treatment including MOUD after discharge.ConclusionsForty-seven percent of residential treatment episodes for Medicaid enrollees are not followed by an outpatient visit or MOUD, and thus are not following best practices.21 pagesen-USAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttps://creativecommons.org/licenses/by-nc-nd/4.0/Follow-upOpioid use disorderMedicaidResidential treatmentOutpatient follow-up and use of medications for opioid use disorder after residential treatment among Medicaid enrollees in 10 statesText